...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell-depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor grafts.
【24h】

Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell-depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor grafts.

机译:抗胸腺细胞球蛋白对部分T细胞耗尽的骨髓移植后定量免疫恢复和移植物抗宿主病的影响:相匹配的相关和相匹配的不相关供体移植受者之间的比较。

获取原文
获取原文并翻译 | 示例

摘要

The effect of antithymocyte globulin (ATG) on quantitative immune recovery and graft-versus-host disease (GVHD) after partially T-cell-depleted bone marrow transplantation was analyzed in 59 and 32 recipients of grafts from matched related donors and matched unrelated donors (MUDs), respectively. The conditioning regimen was similar in all patients, except for ATG which was given only to MUD recipients. Thirteen MUD patients were treated with high-dose (20 mg/kg) ATG and 19 with low-dose (8 mg/kg) ATG. During the posttransplant period, CD3+, CD4+, and CD8+ T-cell numbers and the incidence of acute and chronic GVHD were significantly lower in MUD recipients compared with matched related donor recipients. MUD recipients treated with high-dose ATG showed the worst T-cell and subsets recovery. These data indicate that ATG, often used as part of conditioning regimens in recipients of T-cell-depleted grafts from MUDs, contributes to the severe and prolonged T-cell deficiency that is typical of these patients. On the other hand, it effectively reduces the incidence and severity of GVHD.
机译:在匹配的相关供体和匹配的非相关供体的59和32位接受者中,分析了部分T细胞贫血的骨髓移植后抗胸腺细胞球蛋白(ATG)对定量免疫恢复和移植物抗宿主病(GVHD)的影响( MUD)。除ATG仅适用于MUD接受者外,所有患者的适应方案均相似。 13例MUD患者接受高剂量(20 mg / kg)ATG治疗,19例接受低剂量(8 mg / kg)ATG治疗。在移植后的期间,MUD接受者的CD3 +,CD4 +和CD8 + T细胞数量以及急,慢性GVHD的发生率明显低于相匹配的相关供者。用大剂量ATG治疗的MUD受体表现出最差的T细胞和亚群恢复。这些数据表明,ATG通常用作来自MUD的T细胞贫化的移植受者的条件治疗方案的一部分,导致了这些患者典型的严重和长期T细胞缺乏症。另一方面,它可以有效降低GVHD的发生率和严重性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号